In what way ‘Medical Biotechnology’ and ‘Bioengineering’ are useful for technological development of India ?
Define the two fields, then show with Indian institutions, products and programmes how each contributes to India's technological development, and note the constraints.
Common trap: Weak answers give textbook definitions and generic 'cures diseases'. A top answer separates the two fields, gives Indian examples (recombinant vaccines and insulin, Chitra heart valve, Jaipur Foot, stem-cell guidelines, the 2007 biotech strategy) and links them to self-reliance, affordability, exports and jobs.
SyllabusOld-pattern GS Paper II (2006–12): Developments in Science & Technology — biotechnology and its applications
Model answer
30 marks · 250-word limitMedical biotechnology uses living cells, molecules and genetic engineering to develop diagnostics, vaccines, therapeutics and gene-based medicine. Bioengineering applies engineering principles to biology and medicine, producing implants, devices, prosthetics, imaging systems and engineered tissues. Together they can give India affordable, home-grown health technologies and a knowledge-based industry.
- Affordable recombinant vaccines and drugs
- Rapid diagnostic kits
- Stem cells and regenerative medicine
- Genomics and personalised medicine
- Low-cost implants and devices
- Prosthetics such as the Jaipur Foot
- Exports, jobs and bio-clusters
Medical biotechnology: contributions
- Vaccines and biologics: Indian firms made a recombinant hepatitis B vaccine (Shantha Biotechnics, 1997) and recombinant human insulin, cutting prices sharply; India is a major supplier of vaccines to UNICEF and developing countries.
- Diagnostics: ELISA and PCR-based kits for HIV, hepatitis, malaria and TB allow early, cheap diagnosis in public health programmes.
- Regenerative medicine: Stem-cell research for heart, eye and blood disorders is governed by the ICMR–DBT Guidelines for Stem Cell Research and Therapy (2007).
- Genomics: The Indian Genome Variation Consortium maps genetic diversity of Indian populations, a base for pharmacogenomics and personalised medicine.
Bioengineering: contributions
- Implants and devices: The Sree Chitra Tirunal Institute (Thiruvananthapuram) developed the TTK–Chitra mechanical heart valve and other biomaterials at a fraction of import cost.
- Prosthetics: The Jaipur Foot is a celebrated low-cost artificial limb used by hundreds of thousands of amputees in India and abroad.
- Equipment and tissue: Indigenous imaging, dialysis and monitoring equipment, and tissue-engineered skin and cartilage reduce dependence on imports.
Wider technological gains
- Industry: Biotech parks and clusters in Bangalore, Hyderabad and Pune, and clinical research and contract manufacturing, generate exports and high-skill jobs.
- Policy support: The Department of Biotechnology (1986) and the National Biotechnology Development Strategy (2007) fund research, human resources and public-private partnerships.
- Spillovers: Bioinformatics links biotech with India's IT strength; nanotechnology and biosensors open new device markets.
Constraints
- Gaps: Low R&D spending, weak academia–industry links, a slow multi-agency regulatory system, IPR concerns and ethical issues in clinical trials and stem-cell use.
Medical biotechnology and bioengineering can make India a provider of affordable health technology for itself and the developing world. A single, science-based regulator, higher R&D funding and stronger industry-academia linkages would turn this potential into technological leadership.
Read more — sources
- OfficialDepartment of Biotechnology, National Biotechnology Development Strategy (2007)
- OfficialICMR–DBT, Guidelines for Stem Cell Research and Therapy (2007)
- NCERTBiology (Class XII) — Ch. 11 Biotechnology: Principles and Processes; Ch. 12 Biotechnology and its Applications
More from GS Paper II (old) 2008
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.